"Chemokine CXCL9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An INTEFERON-inducible CXC chemokine that is specific for the CXCR3 RECEPTOR.
| Descriptor ID |
D054370
|
| MeSH Number(s) |
D12.644.276.374.200.120.450 D12.776.467.374.200.120.450 D23.125.300.120.450 D23.469.200.120.450 D23.529.374.200.120.450
|
| Concept/Terms |
Chemokine CXCL9- Chemokine CXCL9
- CXCL9, Chemokine
- CXCL9 Chemokine
- Chemokine, CXCL9
- Monokine Induced by gamma Interferon Chemokine
- SCYB9 Chemokine
- Chemokine, SCYB9
- Small Inducible Cytokine B9
- Chemokine (C-X-C Motif) Ligand 9 Protein
- Mig Chemokine
- Chemokine, Mig
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL9".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL9".
This graph shows the total number of publications written about "Chemokine CXCL9" by people in this website by year, and whether "Chemokine CXCL9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2017 | 1 | 4 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 0 | 4 | 4 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokine CXCL9" by people in Profiles.
-
Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19. Front Immunol. 2021; 12:678661.
-
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner. Viruses. 2021 06 03; 13(6).
-
Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients. Int Immunopharmacol. 2021 Aug; 97:107685.
-
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-? Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome. Front Immunol. 2021; 12:654587.
-
An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight. 2021 01 11; 6(1).
-
Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses. Am J Trop Med Hyg. 2020 12; 103(6):2412-2418.
-
Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adults. Eur J Immunol. 2020 09; 50(9):1412-1414.
-
Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia. Cytokine. 2020 01; 125:154800.
-
Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon ? and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. J Infect Dis. 2019 07 31; 220(5):830-840.
-
Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol. Transpl Immunol. 2019 10; 56:101207.